Search

for
Search:

Research

5 / 225 results

Nanomilled Oral Testosterone Plus Dutasteride Effectively Normalizes Serum Testosterone in Normal Men With Induced Hypogonadism

research Nanomilled Oral Testosterone Plus Dutasteride Effectively Normalizes Serum Testosterone in Normal Men With Induced Hypogonadism

10 citations , February 2008 in “International Journal of Andrology”

This study found that a 400-mg dose of oral testosterone with dutasteride increases serum testosterone levels for 8–10 hours in hypogonadal men, with the nanomilled formulation unaffected by food, suggesting a practical twice-daily therapy option.

research Visit complexity differs between scarring and nonscarring alopecia: A 5-year DataDerm analysis

February 2026 in “Journal of the American Academy of Dermatology”

This study examined alopecia coding trends using the American Academy of Dermatology's DataDerm registry, aiming to assess the impact of evaluation and management CPT coding updates pre- and post-2021 on reimbursement and visit complexity. Results were not reported in the abstract.

research Clinical Development of Topoisomerase-Interactive Drugs

10 citations , January 1994 in “Advances in pharmacology”

This review examines the role of topoisomerase-interacting drugs in cancer treatment and emphasizes the importance of understanding their mechanisms for clinical development, but it presents no new results.

Why We Should Treat COVID-19 Long Hauler Syndromes with Convalescent Plasma; Contained Suppressive Exosomes Are Likely COVID Antigen-Specific

research “Why we should treat COVID-19 Long Hauler Syndromes with Convalescent Plasma; Contained Suppressive Exosomes are likely COVID antigen-specific”

April 2021

This study proposes that neutralizing antibodies and exosomes in convalescent plasma may interfere with early immune responses, potentially explaining limited success of this therapy in active COVID-19 infections.

research Clinical Translation of Targeted Protein Degraders

40 citations , July 2023 in “Clinical Pharmacology & Therapeutics”

This review discusses the progress and challenges of targeted protein degradation therapies, highlighting the increasing number of degraders in cancer clinical trials and the limited diversity in targeted proteins, primarily focusing on those employing CRL4^CRBN as the E3 ligase.

View more "cpt d" in research →

Community Join

3 / 1000+ results

community Starting Pyrilutamide BID. First dose was yesterday. Diffuse thinning. I will put my full regimen below.

91 upvotes 3 years ago

A user's regimen to help with their diffuse thinning, which includes taking Pyrilutamide BID, 1mg finasteride daily, 2.5mg oral minoxidil daily, topical minoxidil since August 2021, LLLT every two days, topical fin, progesterone, melatonin, minoxidil (started one week ago), pumpkin seed oil and not dermarolling; other commenters suggested Nizoral for dandruff control and caution when using pre-mixed products with Pyrilutamide.

community Interpreting pre-finisteride blood panels

2 upvotes 1 year ago

The conversation is about someone planning to start finasteride for hair loss and wanting to interpret pre-treatment blood panels to assess the risk of side effects like gynecomastia. They list various tests to measure hormone levels and other health indicators.

community Hair loss treatments rated (by gpt-4)

249 upvotes 3 years ago

Rating treatments for hair loss, with the help of GPT-4, according to efficacy, evidence and tolerability; a combination of chemicals from research papers, custom compounds, and some suggestions from other users were included.

View more "cpt d" in community →